Pharmacists in Blue Jay, CA Accepting Medicare
8 Pharmacists found. Showing 1 - 8
 Kulsum Sabeen Ahmad, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 State Highway 189, Blue Jay, CA 92317 Phone: 909-336-1275 |
 Steven D Walker, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 State Highway 189, Blue Jay, CA 92317 Phone: 909-336-1275 Fax: 909-337-0791 |
Dr. Pooja Mujumdar Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 Ca Highway 189, Blue Jay, CA 92317 Phone: 909-336-1275 |
Mr. Hans Ignatius Lim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 Highway189, E, Blue Jay, CA 92317 Phone: 909-336-1275 Fax: 909-337-0791 |
Yun Nancy Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 Ca 189 Ste E,, Blue Jay, CA 92317 Phone: 909-336-1275 |
Joshua Blackmore Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 State Highway 189, Blue Jay, CA 92317 Phone: 909-336-1275 |
Fady Hafez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 State Highway 189, Blue Jay, CA 92317 Phone: 909-336-1275 |
Duy Nguyen Tang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27177 State Highway 189, Blue Jay, CA 92317 Phone: 909-336-1275 |
News Archive
Early endovascular thrombectomy plus medical therapy linked to less disability after stroke
In an analysis that included nearly 1,300 patients with large-vessel ischemic stroke, earlier treatment with endovascular thrombectomy (intra-arterial use of a micro-catheter or other device to remove a blood clot) plus medical therapy (use of a clot dissolving agent) compared with medical therapy alone was associated with less disability at 3 months, according to a study appearing in the September 27 issue of JAMA.
Brazil's ANVISA grants registration for child-adapted formulation of benznidazole for Chagas disease
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
ASH offers hematologists a new resource for earning CME credits
The American Society of Hematology (ASH) now offers physicians who diagnose and treat blood disorders a new resource for earning continuing medical education (CME) credits while staying abreast of the latest clinical strategies in the rapidly changing field of hematology.
Can-Fite BioPharma reports financial results, provides update on drug development programs
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2016 and updates on its drug development programs.
› Verified 1 days ago